Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Brantly

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare DiseasesAdam Wanner, Stephen C Groft, J Russell Teagarden, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin DeficiencyTatsiana Beiko, Michael G Janech, Alexander V Alekseyenko, et al.
Human Gene Therapy|May 26, 2011
Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim resultsTerence R Flotte, Bruce C Trapnell, Margaret Humphries, et al.
Gastroenterology|December 13, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver DiseaseRohit Loomba, Virginia C Clark, Mattias Mandorfer, et al.
The European Respiratory Journal|March 8, 2014
Circulating polymers in α1-antitrypsin deficiencyLu Tan, Jennifer A Dickens, Dawn L Demeo, et al.
Gastroenterology|July 4, 2024
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)Virginia C Clark, Charlie Strange, Pavel Strnad, et al.
The Journal of Clinical Investigation|November 16, 2013
Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expressionChristian Mueller, Jeffrey D Chulay, Bruce C Trapnell, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare DiseasesAdam Wanner, Stephen C Groft, J Russell Teagarden, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin DeficiencyTatsiana Beiko, Michael G Janech, Alexander V Alekseyenko, et al.
Human Gene Therapy|May 26, 2011
Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim resultsTerence R Flotte, Bruce C Trapnell, Margaret Humphries, et al.
Gastroenterology|December 13, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver DiseaseRohit Loomba, Virginia C Clark, Mattias Mandorfer, et al.
The European Respiratory Journal|March 8, 2014
Circulating polymers in α1-antitrypsin deficiencyLu Tan, Jennifer A Dickens, Dawn L Demeo, et al.
Gastroenterology|July 4, 2024
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)Virginia C Clark, Charlie Strange, Pavel Strnad, et al.
The Journal of Clinical Investigation|November 16, 2013
Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expressionChristian Mueller, Jeffrey D Chulay, Bruce C Trapnell, et al.
Pageof 7